English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Arthritis 2020-Aug

Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
Augusta Ortolan
Mariagrazia Lorenzin
Mara Felicetti
Roberta Ramonda

Keywords

Abstract

Objective: the aim of our systematic review and meta-analysis was to investigate whether overweight/obesity are associated with higher disease activity measures in axial spondyloarthritis (axSpA) patients.

Methods: MEDLINE, PubMed and Web of Science were searched using key terms corresponding to population (axSpA), exposure (overweight/obesity) and outcome (Bath Ankylosing Spondylitis Disease Activity Index, BASDAI; Ankylosing spondylitis disease activity score, ASDAS). Predefined inclusion criteria were: 1) adult axSpA patients 2) exposure classified according to Body Mass Index-BMI-; 3) BASDAI/ASDAS reported for each BMI group; 4) observational studies. Newcastle-Ottawa Scale for cohort, cross-sectional and case-control studies was used for quality check. Random-effects meta-analysis was used to pool results, which were expressed as mean difference (MD) in BASDAI and ASDAS between BMI groups, with 95% confidence intervals (95%CI).

Results: ten articles were included in the meta-analysis. The MD in BASDAI between normal BMI and overweight/obese patients was -0.38 (95%CI:-0.56,-0.21, p<0.0001); the MD in ASDAS between the same groups was -0.19 (95%CI:-0.29,-0.09, p<0.0001). The MD in BASDAI between normal BMI/overweight patients was -0.09 (95%CI:-0.33,0.15, p=0.45) and MD between normal BMI/obese patients was -0.78 (95%CI:-1.07,-0.48, p<0.0001). As for ASDAS, the MD between normal BMI/overweight patients was -0.02 (95%CI:-0.19,0.15, p=0.79) and MD between normal BMI/obese patients was (-0.42; 95%CI:-0.60,-0.23, p<0.0001).

Conclusions: overweight and obese axSpA patients tend to present higher disease activity scores compared to normal BMI patients. This difference seems to be clinically meaningful only for the comparison between obese and normal BMI patients, and more for BASDAI than ASDAS.

Keywords: Ankylosing Spondylitis Disease Activity Score (ASDAS); Bath Ankylosing Spondylitis Disease Activity Index (BASDAI); Body Mass Index (BMI); Spondyloarthritis; disease activity.

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge